Antithrombotiques et gestes invasifsMOTTIER, Dominique.MT. Médecine thérapeutique. 2007, Vol 12, issn 1264-6520, 80 p., NSSerial Issue

Place et intérêt des études pharmacocinétiques et pharmacodynamiques par approche population dans le développement des antithrombotiquesHULOT, Jean-Sébastien.MT. Médecine thérapeutique. 2006, Vol 12, Num 3, pp 175-182, issn 1264-6520, 8 p.Article

Treatment of Venous ThromboembolismMERLI, Geno J.The American journal of medicine. 2008, Vol 121, Num 11A, issn 0002-9343, S2-S9, SUPConference Paper

Treatment of Venous ThromboembolismWELLS, Philip S; FORGIE, Melissa A; RODGER, Marc A et al.JAMA, the journal of the American Medical Association. 2014, Vol 311, Num 7, pp 717-728, issn 0098-7484, 12 p.Article

LXR as a novel antithrombotic targetSPYRIDON, Michael; MORAES, Leonardo A; JONES, Chris I et al.Blood. 2011, Vol 117, Num 21, pp 5751-5761, issn 0006-4971, 11 p.Article

New Antithrombotic DrugsGROSS, P. L; WEITZ, J. I.Clinical pharmacology and therapeutics. 2009, Vol 86, Num 2, pp 139-146, issn 0009-9236, 8 p.Article

Les antithrombotiques : Tradition et innovationHAINAUT, Ph.Louvain médical. 2005, Vol 124, Num 9, pp S176-S179, issn 0024-6956Conference Paper

Antithrombins : their potential as antithrombotic agentsWEITZ, J. I; HIRSH, J.Annual review of medicine. 1992, Vol 43, pp 9-16, issn 0066-4219Article

Les oligosaccharides hépariniques de synthèse : une nouvelle approche pour l'étude de l'héparine au niveau moléculaireChoay, Jean; Jozefowicz, Marcel.1989, 85 p.Thesis

Les traitements antithrombotiques = AntithromboticsLECOMPTE, T.La Lettre du cardiologue. 2004, Num NOV, pp 23-25, issn 0761-5035, 3 p., NSConference Paper

Pharmacologie expérimentale du sulfate de dermatane et de ses dérivésDol, Frédérique; Boneu, Bernard.1989, 162 p.Thesis

Thromboses expérimentales: rôle de la thrombine, et inhibition par l'hirudine et d'autres antithrombotiques = Experimental thrombosis: thrombin function and inhibitory by hirudin and other antithromboticsDe Vaulx-Freund, Monique; Cazenave, Jean-Pierre.1992, 224 p.Thesis

Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 updateCUISSET, Thomas; VALGIMIGIL, Marco; MUDRA, Harald et al.EuroIntervention. 2010, Vol 6, Num 1, pp 39-45, issn 1774-024X, 7 p.Article

Mécanismes d'action et principales données pharmacologiques des nouveaux médicaments antithrombotiques = Mechanisms of action and principal pharmacological properties of the new antithrombotic agentsSAMAMA, M. M; GEROTZIAFAS, G. T.La Lettre du pneumologue. 2003, Vol 6, Num 3, pp 122-128, issn 1292-5977, 7 p.Article

Current developments in glycosaminoglycans and related drugs : abstracts, Kiel, Germany, Frebruary 1990Seminars in thrombosis and hemostasis. 1991, Vol 17, pp 240-245, issn 0094-6176, SUP2Conference Paper

Hémostase Le point sur les nouveaux antithrombotiques : Nouveautés en médecine 2009: deuxième partie = Update on new antithrombotic treatmentsBOEHLEN, F; TIREFORT-DIMITROVA, Y; DE MOERLOOSE, P et al.Revue médicale suisse. 2010, Vol 6, Num 232, pp 109-112, issn 1660-9379, 4 p.Article

Pharmacodynamics of a sulfated lactobionic acid amide-derived antithrombotic agent (aprosulate) in primatesFAREED, J; COKER, S; IQBAL, O et al.Seminars in thrombosis and hemostasis. 1991, Vol 17, pp 147-152, issn 0094-6176, SUP2Article

Apixaban for Extended Treatment of Venous ThromboembolismAGNELLI, Giancarlo; BULLER, Harry R; COHEN, Alexander et al.The New England journal of medicine. 2013, Vol 368, Num 8, pp 699-708, issn 0028-4793, 10 p.Article

Pregnancy-Associated Venous Thromboembolism: Prevention and TreatmentBATES, Shannon M.Seminars in hematology. 2011, Vol 48, Num 4, pp 271-284, issn 0037-1963, 14 p.Article

Dabigatran Etexilate: Clinical Implications in Dermatologic SurgeryBOTA, James P; LEBLANC, Keith G; SHEEHAN, Daniel J et al.Dermatologic surgery. 2012, Vol 38, Num 4, pp 675-676, issn 1076-0512, 2 p.Article

Selected new antithrombotic agents and neuraxial anaesthesia for major orthopaedic surgery : management strategiesROSENCHER, N; BONNET, M.-P; SESSLER, D. I et al.Anaesthesia. 2007, Vol 62, Num 11, pp 1154-1160, issn 0003-2409, 7 p.Article

Monitoring the new antithrombotic drugsWALENGA, Jeanine M; HOPPENSTEADT, Debra A.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 6, pp 683-695, issn 0094-6176, 13 p.Conference Paper

Molecular and functional heterogeneity in dermatan sulfate preparationsFAREED, J; HOPENSTEADT, D; WALENGA, J. M et al.Seminars in thrombosis and hemostasis. 1991, Vol 17, pp 174-180, issn 0094-6176, SUP2Article

Optimisation of the assa\ys for the measurement of clotting factor activity in the presence of rivaroxabanGEROTZIAFAS, Grigoris T; BACCOUCHE, Hela; SASSI, Mouna et al.Thrombosis research. 2012, Vol 129, Num 1, pp 101-103, issn 0049-3848, 3 p.Article

New Antithrombotic Drugs: Potential for Use in OncologyLEVINE, Mark N.Journal of clinical oncology. 2009, Vol 27, Num 29, pp 4912-4918, issn 0732-183X, 7 p.Article